YOUNG WILLIAM D 4

What Happened

• William D. Young, a director of Autolus Therapeutics plc (AUTL), was granted two RSU awards on June 29, 2026: 31,667 RSUs and 47,500 RSUs (total 79,167 RSUs). Each award was recorded at $0.00 (no purchase price) and is reported as a derivative/award.
• These RSUs are contingent rights to receive American Depositary Shares (ADSs), and each ADS is convertible into one ordinary share (see footnote F1). The RSUs vest in one installment on June 29, 2027 (footnote F2).

Key Details

• Transaction date: 2026-06-29; Filing date: 2026-07-01.
• Grants: 31,667 RSUs @ $0.00 and 47,500 RSUs @ $0.00 (total 79,167 RSUs).
• Shares/ADS owned after the transaction: not specified in the provided filing data.
• Notable footnotes:
  • F1: Each RSU = contingent right to one ADS; each ADS convertible to one ordinary share.
  • F2: RSUs vest in one installment on June 29, 2027.
  • F3: Related share options (if applicable) vest in 12 equal monthly installments beginning July 29, 2026.
• Filing timeliness: Filing covers the 6/29/2026 transactions and was submitted on 7/1/2026; no late-filing flag was indicated in the provided data.

Context

• This was an equity award (not an open-market purchase or sale). RSUs are a common form of compensation and represent a future right to receive ADSs/shares upon vesting rather than an immediate cash purchase.
• On vesting (6/29/2027), the RSUs should convert into ADSs (and then ordinary shares if elected), at which point the shares would be reportable as beneficial ownership.